Allen David R 4

What Happened

• David R. Allen, a director of Marimed Inc. (MRMD), was granted 75,000 restricted stock units (RSUs) on 2026-06-04. The Form 4 reports the grant as a derivative acquisition (code A) at $0.00 immediate price/value. The filing (Accession 0001522767-26-000111) was submitted on 2026-06-08.
• This was an equity award (not an open-market purchase or sale); RSUs are compensation and do not involve an outlay of cash at grant.

Key Details

• Transaction date: 2026-06-04; Report filed: 2026-06-08 (timely).
• Grant: 75,000 RSUs, reported at $0.00 (derivative award).
• Shares owned after transaction: Not disclosed in this Form 4.
• Footnotes: F1 — RSUs convert to common stock on a one-for-one basis. F2 — The RSUs vest in full one year from the grant date per the award agreement.
• Remarks: The award is the annual equity grant under Marimed's non-employee director compensation program.

Context

• RSUs are a deferred equity award: no shares are issued and typically no taxable event occurs until vesting (subject to tax rules). Upon vesting the RSUs convert to common shares one-for-one, with value depending on MRMD’s share price at that time.
• Director RSU grants are routine compensation for non-employee directors and do not by themselves indicate the director is buying or selling stock.